Menstrual tracking apps lack evidence of health and performance benefits
Digital menstrual tracking risks creating more harm than benefit and requires greater scrutiny, warn experts in The BMJ today.
Read original article on The Medical News →Related news
-
OnDosis and Adare Pharma Solutions announce strategic collaboration to advance OnDosis's lead U.S. ADHD program
United Kingdom
-
New antibiotic combinations aim to prevent recurrent bacterial vaginosis
United Kingdom
-
Study examines the real-world use of GLP-1 RA drugs in children and young people
United Kingdom
-
Insurance hurdles and costs hinder access to blood cancer drugs
United Kingdom
-
Research reveals major impact of climate change on skin health worldwide
United Kingdom
-
COVID fatigue linked to reduced brain blood flow
United Kingdom
-
Long‑acting medicines could make daily tablets a thing of the past for some patients
United Kingdom
-
Autonomous AI could create capacity for thousands more dermatology appointments, real-world study finds
United Kingdom